UP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
Perrigo Company is recalling UP AND UP Childrens Acetaminophen oral suspension due to contamination from a recalled excipient used in manufacturing. The product was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a CGMP deviation (contaminated excipient). The source text does not report any illnesses, injuries, or hospitalizations. The recall is precautionary based on the manufacturing deviation, making it a moderate-severity voluntary precautionary recall.
Plain-English summary
Perrigo Company PLC is recalling UP AND UP Childrens Acetaminophen (Acetaminophen Child Bubble Gum Flavored Oral Suspension, 160 mg/5 ml, 4 FL OZ per bottle) distributed under the NDC 11673-105-26. The recall affects batch 1CK0998 with expiration date 01/31/2023, totaling 4,992 bottles.
The recall was initiated because the product was manufactured using a contaminated excipient that had been recalled by the excipient supplier. This represents a deviation from good manufacturing practices (CGMP).
The affected product was distributed nationwide in the USA. Consumers who have purchased this product should discontinue use and consult their healthcare provider if they have any concerns.
The recalled product
- Product
- UP AND UP CHILDRENS ACETAMINOPHEN (ACETAMINOPHEN)
- Brand
- UP AND UP CHILDRENS ACETAMINOPHEN
- Manufacturer
- Perrigo Company PLC
- Affected units
- 4,992
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1CK0998
- Exp 01/31/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same brand · UP AND UP CHILDRENS ACETAMINOPHEN
- ModerateUP AND UP Children's Acetaminophen Oral Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same manufacturer · Perrigo Company PLC
See all →- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEquate Infant Pain and Fever Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever recalled due to contaminated excipient
FDA (Drugs) · 2022-03-02
Same hazard · contaminated excipient
See all →- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Similar recalls
- ModerateL. Perrigo Recalls Infants' Acetaminophen Due to Unmarked Dosing Syringes
FDA (Drugs) · 2013-11-27
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
- ModerateL. Perrigo Recalls Infants' Acetaminophen Suspension Due to Dosing Syringe Markings
FDA (Drugs) · 2013-11-27
- ModerateL. Perrigo Recalls Infants' Pain and Fever Acetaminophen Due to Dosing Syringe Defect
FDA (Drugs) · 2013-11-27
- HighChildren's Acetaminophen Suspension Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-12-13
- ModeratePrecision Dose Recalls Children's Acetaminophen Due to Misleading Labeling
FDA (Drugs) · 2013-04-24